- Home
- GORV vs RVPH Comparison
GORV vs RVPH Comparison
Compare GORV & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- RVPH
- Stock Information
- Founded
- GORV 1976
- RVPH 2006
- Country
- GORV United States
- RVPH United States
- Employees
- GORV N/A
- RVPH N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- GORV Consumer Discretionary
- RVPH Health Care
- Exchange
- GORV Nasdaq
- RVPH Nasdaq
- Market Cap
- GORV 25.3M
- RVPH 32.8M
- IPO Year
- GORV 2015
- RVPH N/A
- Fundamental
- Price
- GORV $0.24
- RVPH $0.40
- Analyst Decision
- GORV Hold
- RVPH Strong Buy
- Analyst Count
- GORV 2
- RVPH 5
- Target Price
- GORV $2.00
- RVPH $9.00
- AVG Volume (30 Days)
- GORV 2.3M
- RVPH 3.4M
- Earning Date
- GORV 08-15-2025
- RVPH 08-13-2025
- Dividend Yield
- GORV N/A
- RVPH N/A
- EPS Growth
- GORV N/A
- RVPH N/A
- EPS
- GORV N/A
- RVPH N/A
- Revenue
- GORV $767,257,000.00
- RVPH N/A
- Revenue This Year
- GORV $15.65
- RVPH N/A
- Revenue Next Year
- GORV $20.54
- RVPH N/A
- P/E Ratio
- GORV N/A
- RVPH N/A
- Revenue Growth
- GORV N/A
- RVPH N/A
- 52 Week Low
- GORV $0.13
- RVPH $0.30
- 52 Week High
- GORV $3.56
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- GORV 48.60
- RVPH 33.44
- Support Level
- GORV $0.22
- RVPH $0.35
- Resistance Level
- GORV $0.26
- RVPH $0.83
- Average True Range (ATR)
- GORV 0.02
- RVPH 0.06
- MACD
- GORV 0.00
- RVPH -0.01
- Stochastic Oscillator
- GORV 51.29
- RVPH 17.36
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.